AbbVie is spearheading a new battle in pharma's long-running fight to reform the federal government’s 340B drug discount ...

In connection with the deal, Assertio has divested the rest of its assets to New Jersey generics and branded drugmaker ...

Robert F. Kennedy Jr. is starting a podcast. Unveiling the show on social media, the Department of Health and Human Services ...

In December, Vanda Pharmaceuticals gained FDA approval for its motion sickness drug Nereus. But a much larger patient population may be in store for the oral therapy as the Washington, D.C.-based ...

After more than a decade in charge of the most influential organization representing the U.S. pharmaceutical industry, the ...

Japan’s Shionogi is joining the spate of drugmakers to announce manufacturing commitments in the U.S. since last year, albeit ...

Pfizer is making more changes to its layout in California by stepping away from a South San Francisco office site that used ...

Biogen has forged a settlement with investors who claimed the company misled them in describing how it gained a controversial ...

With another year of double-digit revenue growth in the books, Amgen’s longtime helmsman Robert Bradway continues to sit ...

Cognito Therapeutics is partnering with a nonprofit to “Change the D-Word,” aiming to eliminate the use of “dementia,” a ...

One year into his tumultuous tenure as the FDA’s commissioner, Marty Makary, M.D., has laid out ambitious internal goals and ...

U.S. Olympic gold medal-winning athlete Lindsey Vonn is once again teaming up with infectious disease biopharma Invivyd for a ...